{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:17:05Z","timestamp":1770430625879,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T00:00:00Z","timestamp":1072051200000},"content-version":"vor","delay-in-days":873,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To pilot a protocol for a national multicentre randomised trial in which a low molecular weight heparin will be compared with placebo for prevention of venous thrombotic events occurring within six weeks after caesarean section.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Double\u2010blind randomised controlled trial.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Tertiary care centre.<\/jats:p><jats:p><jats:bold>Participants\n\t\t\t\t\t<\/jats:bold> Seventy\u2010six women having had a caesarean section, 37 in the control group and 39 in the Dalteparin group.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Consenting patients having had an emergency or elective caesarean section were commenced on study medication 6\u201324 hours post\u2010operatively. The study medication, dalteparin 2500iu or saline, was given subcutaneously once daily for four or five days post\u2010operatively depending on the patient's length of stay. Patients were reviewed in hospital for operative outcomes and contacted at two and six weeks post\u2010operatively.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Of the 141 women given information about the trial, 76 (54%) consented to participate. Follow up to six weeks was achieved in all women who were recruited. More women in the placebo arm had general anaesthesia, but otherwise the two groups had similar characteristics at randomisation. There was only one occurrence of a deep vein thrombosis during the study. This patient was in the treatment arm and the thrombosis occurred between two and six weeks post\u2010operatively. All other outcomes were similar in the two groups.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> Our experience of a 26% recruitment rate, the thrombosis rate of 1.3% (95% CI 0.03\u20107.1%) and the contactability of all participants two and six weeks post\u2010operatively, indicates that this study is feasible.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2001.00198.x","type":"journal-article","created":{"date-parts":[[2003,12,22]],"date-time":"2003-12-22T17:08:18Z","timestamp":1072112898000},"page":"835-839","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A randomised double\u2010blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study"],"prefix":"10.1111","volume":"108","author":[{"given":"Robert F.","family":"Burrows","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eng T.","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Gallus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euan M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,12,22]]},"reference":[{"key":"e_1_2_6_2_2","volume-title":"Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991\u20131993","author":"Hibbard B.M.","year":"1996"},{"key":"e_1_2_6_3_2","volume-title":"Report on confidential enquiries into maternal deaths in the United Kingdom 1994\u20131996","author":"Lewis G.","year":"1998"},{"key":"e_1_2_6_4_2","volume-title":"Report of the RCOG Working Party on Prophylaxis against Thromboembolism in Gynaecology and Obstetrics","author":"Shaw R.W.","year":"1995"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00009"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1972.04180020014004"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-6-891"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0038-1656357","article-title":"Ventilation\u2010perfusion lung scanning and the diagnosis of pulmonary embolism. Improvement of observer agreement by the use of a lung segment reference chart","volume":"68","author":"Lensing A.W.","year":"1992","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1992.tb03529.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806113382415"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199710000-00031"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-7-545"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198610093151503"},{"issue":"156","key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinte.1996.00440080039005","article-title":"Ardeparin (LMWH) vers graduated compression stockings for the prevention of venous thromboembolism. A randomised controlled trial in patients undergoing knee surgery","author":"Levine M.N.","year":"1996","journal-title":"Arch Int Med"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800751105"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0038-1661658","article-title":"Low molecular weight heparin (Kabi 2165) as thromboprophylaxis in elective visceral surgery: a randomized, double\u2010blind study versus unfractionated heparin","volume":"56","author":"Koller M.","year":"1986","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92614-Y"},{"key":"e_1_2_6_18_2","first-page":"21","article-title":"An international multicentre study: Clivarin (R) in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin (R) Assessment Group","volume":"4","author":"Boneu B.","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800831117"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322003"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies","volume":"77","author":"Hunt B.J.","year":"1997","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0038-1646338","article-title":"Use of low molecular weight heparin in pregnancy","volume":"68","author":"Melissari E.","year":"1992","journal-title":"Thromb Haemost"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb13014.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70403-4"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00452-1"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2001.00198.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2001.00198.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:14:31Z","timestamp":1697559271000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2001.00198.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1111\/j.1471-0528.2001.00198.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2001.00198.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2003-12-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}